Latest Regenerative Perinatal News

Wharton’s Jelly Composition Analysis: Growth Factors, Cytokines, Hyaluronic Acid, and Extracellular Vesicles Support its Potential Role in Regenerative Medicine (2020 Study)

Wharton’s Jelly-Derived Mesenchymal Stem Cells Shows Promise for Traumatic Brain Injury: Results from Phase I Study (2024)

MEDIPOST’s stem cell therapy regenerates stronger cartilage than microdrilling, clears path to US phase 3

Florida Republicans introduce two bills to allow umbilical stem cell therapy: Here’s what you should know

Celularity gets 361 nod from FDA for its amniotic derived wound care products, Natalin and Acelagraft™ 

MEDIPOST preparing for Phase 3 clinical trials of its umbilical cord stem cell product, Cartistem, appoints 5 new executives

x
Subscribe
Subscribe

Stay updated on Regenerative Medicine

Subscribe